STEMPOINT CAPITAL LP
Filing Date
Global Rank
#2,623
/ 8,700
▲ 833
Top Industry
Biotechnology
90.3%
Period ended 2 months ago
Filed Aug 14, 2026 · 29d
11 quarters · since Dec 2023
Portfolio Concentration
75 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
6.6%
−3.4 pts
Top 5
26.7%
−4.7 pts
Top 10
41.4%
−4.7 pts
HHI
273
Diversified−62
Portfolio Trend
11 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.7% | $579,986,135 |
| Financial Services | 0.3% | $1,826,579 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
19 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ERAS | Erasca, Inc. | +1,526,052 | 1,765,913 | $28,777,526 | |
| TNGX | Tango Therapeutics, Inc. | +1,122,100 | 1,323,019 | $38,406,573 | |
| RLMD | Relmada Therapeutics, Inc. | +862,684 | 1,460,093 | $10,103,843 | |
| ZURA | Zura Bio Ltd | +614,695 | 1,368,215 | $8,072,468 | |
| SRZN | Surrozen, Inc./DE | +406,817 | 602,798 | $15,642,608 | |
| TYRA | Tyra Biosciences, Inc. | +339,577 | 632,754 | $20,210,162 | |
| ALKS | Alkermes plc. | +167,523 | 248,015 | $12,995,986 | |
| SLDB | Solid Biosciences Inc. | +163,377 | 358,780 | $3,584,212 | |
| BIOA | BioAge Labs, Inc. | +125,517 | 464,171 | $11,376,831 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | +115,349 | 200,851 | $19,578,955 | |
| WHWK | Whitehawk Therapeutics, Inc. | +81,668 | 1,021,037 | $4,676,349 | |
| CCCC | C4 Therapeutics, Inc. | +70,412 | 523,648 | $2,445,436 | |
| MLYS | Mineralys Therapeutics, Inc. | +69,308 | 602,686 | $16,260,468 | |
| ROIV | Roivant Sciences Ltd. | +62,608 | 448,408 | $12,370,159 | |
| CELC | Celcuity Inc. | +38,141 | 98,203 | $10,273,997 | |
| SPRB | Spruce Biosciences, Inc. | +35,028 | 41,388 | $2,234,952 | |
| SION | Sionna Therapeutics, Inc. | +22,886 | 59,426 | $2,614,149 | |
| QURE | uniQure N.V. | +10,049 | 88,115 | $4,058,576 | |
| MPLT | MapLight Therapeutics, Inc. | +6,906 | 106,906 | $3,831,511 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | −896,350 | 239,146 | $13,153,030 | |
| IMVT | Immunovant, Inc. | −569,967 | 276,527 | $10,654,585 | |
| EYPT | EyePoint, Inc. | −472,293 | 338,471 | $4,840,135 | |
| ARQT | Arcutis Biotherapeutics, Inc. | −314,847 | 98,945 | $2,594,337 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | −285,381 | 384,304 | $6,902,099 | |
| RVMD | Revolution Medicines, Inc. | −191,689 | 189,943 | $30,081,625 | |
| DFTX | Definium Therapeutics, Inc. | −188,359 | 137,124 | $6,450,312 | |
| GPCR | Structure Therapeutics Inc. | −162,089 | 38,178 | $2,049,013 | |
| HLXC | Helix Acquisition Corp. III | −133,357 | 171,671 | $1,826,579 | |
| NAMS | NewAmsterdam Pharma Co N.V. | −103,069 | 77,589 | $2,629,491 | |
| ACAD | Acadia Pharmaceuticals Inc | −99,399 | 143,167 | $3,622,125 | |
| ALMS | Alumis Inc. | −93,830 | 135,736 | $3,819,611 | |
| TENX | Tenax Therapeutics, Inc. | −92,427 | 96,273 | $1,400,772 | |
| CLDX | Celldex Therapeutics, Inc. | −75,855 | 178,412 | $6,638,710 | |
| XENE | Xenon Pharmaceuticals Inc. | −64,680 | 76,075 | $4,591,887 | |
| SYRE | Spyre Therapeutics, Inc. | −60,680 | 106,926 | $9,492,890 | |
| PTGX | Protagonist Therapeutics, Inc | −56,274 | 16,303 | $1,998,421 | |
| CYTK | Cytokinetics Inc | −53,974 | 75,603 | $6,440,619 | |
| CGON | CG Oncology, Inc. | −46,273 | 159,349 | $11,321,746 | |
| SABS | SAB Biotherapeutics, Inc. | −32,369 | 342,631 | $1,336,260 | |
| BHVN | Biohaven Ltd. | −30,291 | 1,564,200 | $16,360,296 | |
| ABVX | Abivax S.A. | −30,134 | 283,657 | $37,800,131 | |
| PRAX | Praxis Precision Medicines, Inc. | −19,024 | 37,243 | $12,468,583 | |
| LBRX | Lb Pharmaceuticals Inc | −18,215 | 31,785 | $1,031,582 | |
| ELVN | Enliven Therapeutics, Inc. | −16,524 | 346,914 | $17,605,885 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International, plc | 209,234 | $13,380,514 | |
| TRAX | First Tracks Biotherapeutics, Inc. | 622,723 | $12,529,186 | |
| ORKA | Oruka Therapeutics, Inc. | 116,461 | $11,083,593 | |
| CLYM | Climb Bio, Inc. | 742,745 | $9,685,394 | |
| IFRX | InflaRx N.V. | 3,228,255 | $7,231,291 | |
| OVID | Ovid Therapeutics Inc. | 2,417,283 | $6,502,491 | |
| EQ | Equillium, Inc. | 2,016,607 | $6,453,142 | |
| DMRA | Damora Therapeutics, Inc. | 216,194 | $5,623,205 | |
| IVA | Inventiva S.A. | 1,426,320 | $5,391,489 | |
| IPSC | Century Therapeutics, Inc. | 2,146,182 | $5,258,145 | |
| AURA | Aura Biosciences, Inc. | 714,280 | $5,071,388 | |
| PSNL | Personalis, Inc. | 717,783 | $4,131,042 | |
| CMPS | COMPASS Pathways plc | 284,769 | $4,029,481 | |
| AVLN | Avalyn Pharma Inc. | 118,000 | $3,884,560 | |
| AXSM | Axsome Therapeutics, Inc. | 15,375 | $3,763,338 | |
| GLUE | Monte Rosa Therapeutics, Inc. | 153,544 | $3,715,764 | |
| CBIO | Crescent Biopharma, Inc. | 182,382 | $3,282,876 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 39,198 | $3,195,028 | |
| KOD | Kodiak Sciences Inc. | 75,872 | $2,955,973 | |
| MNPR | Monopar Therapeutics | 30,125 | $2,789,273 | |
| RAPP | Rapport Therapeutics, Inc. | 66,582 | $2,774,471 | |
| CUE | Cue Biopharma, Inc. | 66,995 | $2,114,362 | |
| CALC | CalciMedica, Inc. | 1,244,864 | $1,282,209 | |
| CLRB | Cellectar Biosciences, Inc. | 354,938 | $986,727 | |
| PRQR | ProQR Therapeutics N.V. | 431,054 | $801,760 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 1,365,743 | $28,489,756 | |
| MBX | MBX Biosciences, Inc. | 499,469 | $14,909,149 | |
| DYN | Dyne Therapeutics, Inc. | 506,075 | $9,175,139 | |
| EWTX | Edgewise Therapeutics, Inc. | 290,864 | $9,162,216 | |
| DNLI | Denali Therapeutics Inc. | 426,561 | $8,189,971 | |
| NRIX | Nurix Therapeutics, Inc. | 315,226 | $4,886,003 | |
| EVMN | Evommune, Inc. | 193,777 | $4,454,933 | |
| FTH | Faeth Therapeutics, Inc. | 132,873 | $4,188,156 | |
| JNJ | Johnson & Johnson | 15,415 | $3,768,042 | |
| XFOR | X4 Pharmaceuticals, Inc | 850,742 | $3,513,564 | |
| PCVX | Vaxcyte, Inc. | 59,061 | $3,432,034 | |
| IVVD | Invivyd, Inc. | 1,874,546 | $2,436,909 | |
| JBIO | Jade Biosciences, Inc. | 154,034 | $2,164,177 | |
| TWST | Twist Bioscience Corp | 43,110 | $2,048,587 | |
| AVTX | Avalo Therapeutics, Inc. | 134,742 | $2,011,698 | |
| IONS | Ionis Pharmaceuticals Inc | 26,385 | $1,981,249 | |
| IMCR | Immunocore Holdings plc | 63,543 | $1,915,821 | |
| — | 58,020 | $1,502,718 | ||
| LPCN | Lipocine Inc. | 160,420 | $1,281,755 | |
| EW | Edwards Lifesciences Corp | 24,588 | $1,169,207 | |
| CAPR | Capricor Therapeutics, Inc. | 37,592 | $1,142,796 | |
| STRO | Sutro Biopharma, Inc. | 23,295 | $580,278 | |
| BWX | State Street SPDR Bloomberg International Treasury Bond ETF | 150,000 | $164,250 | |
| SPY | Spdr S&P 500 ETF Trust | 50,000 | $85,500 | |
| QQQ | Invesco Qqq Trust, Series 1 | 40,000 | $74,200 | |
| No positions match the current search. | ||||
75 tracked positions ·
$581,812,714 total
· filing declares
85 positions · $580,521,914
· as of Jun 30, 2026
Showing 1–50
of 75 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TNGX |
Tango Therapeutics, Inc.
CALL
+ SHARES
Healthcare
|
Added | 1,323,019 | $38,406,573 | 6.60% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 283,657 | $37,800,131 | 6.50% | |
| RVMD |
Revolution Medicines, Inc.
PUT
+ SHARES
Healthcare
|
Reduced | 189,943 | $30,081,625 | 5.17% | |
| ERAS |
Erasca, Inc.
PUT
+ SHARES
Healthcare
|
Added | 1,765,913 | $28,777,526 | 4.95% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Added | 632,754 | $20,210,162 | 3.47% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Added | 200,851 | $19,578,955 | 3.37% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Reduced | 346,914 | $17,605,885 | 3.03% | |
| BHVN |
Biohaven Ltd.
CALL
+ SHARES
Healthcare
|
Reduced | 1,564,200 | $16,360,296 | 2.81% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 602,686 | $16,260,468 | 2.79% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Added | 602,798 | $15,642,608 | 2.69% | |
| KNSA |
Kiniksa Pharmaceuticals International, plc
Healthcare
|
NEW | 209,234 | $13,380,514 | 2.30% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Reduced | 239,146 | $13,153,030 | 2.26% | |
| ALKS |
Alkermes plc.
Healthcare
|
Added | 248,015 | $12,995,986 | 2.23% | |
| TRAX |
First Tracks Biotherapeutics, Inc.
Healthcare
|
NEW | 622,723 | $12,529,186 | 2.15% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Reduced | 37,243 | $12,468,583 | 2.14% | |
| ROIV |
Roivant Sciences Ltd.
PUT
+ SHARES
Healthcare
|
Added | 448,408 | $12,370,159 | 2.13% | |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
Added | 464,171 | $11,376,831 | 1.96% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Reduced | 159,349 | $11,321,746 | 1.95% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 116,461 | $11,083,593 | 1.91% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Reduced | 276,527 | $10,654,585 | 1.83% | |
| CELC |
Celcuity Inc.
Healthcare
|
Added | 98,203 | $10,273,997 | 1.77% | |
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
Added | 1,460,093 | $10,103,843 | 1.74% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
NEW | 742,745 | $9,685,394 | 1.66% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 106,926 | $9,492,890 | 1.63% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
Added | 1,368,215 | $8,072,468 | 1.39% | |
| IFRX |
InflaRx N.V.
Healthcare
|
NEW | 3,228,255 | $7,231,291 | 1.24% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Reduced | 384,304 | $6,902,099 | 1.19% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 178,412 | $6,638,710 | 1.14% | |
| OVID |
Ovid Therapeutics Inc.
Healthcare
|
NEW | 2,417,283 | $6,502,491 | 1.12% | |
| EQ |
Equillium, Inc.
Healthcare
|
NEW | 2,016,607 | $6,453,142 | 1.11% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
Reduced | 137,124 | $6,450,312 | 1.11% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 75,603 | $6,440,619 | 1.11% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
NEW | 216,194 | $5,623,205 | 0.97% | |
| IVA |
Inventiva S.A.
Healthcare
|
NEW | 1,426,320 | $5,391,489 | 0.93% | |
| IPSC |
Century Therapeutics, Inc.
Healthcare
|
NEW | 2,146,182 | $5,258,145 | 0.90% | |
| AURA |
Aura Biosciences, Inc.
Healthcare
|
NEW | 714,280 | $5,071,388 | 0.87% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
Reduced | 338,471 | $4,840,135 | 0.83% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
Reduced | 170,378 | $4,681,987 | 0.80% | |
| WHWK |
Whitehawk Therapeutics, Inc.
Healthcare
|
Added | 1,021,037 | $4,676,349 | 0.80% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 76,075 | $4,591,887 | 0.79% | |
| PSNL |
Personalis, Inc.
CALL
+ SHARES
Healthcare
|
NEW | 717,783 | $4,131,042 | 0.71% | |
| QURE |
uniQure N.V.
Healthcare
|
Added | 88,115 | $4,058,576 | 0.70% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
NEW | 284,769 | $4,029,481 | 0.69% | |
| AVLN |
Avalyn Pharma Inc.
Healthcare
|
NEW | 118,000 | $3,884,560 | 0.67% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
Added | 106,906 | $3,831,511 | 0.66% | |
| ALMS |
Alumis Inc.
Healthcare
|
Reduced | 135,736 | $3,819,611 | 0.66% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
NEW | 15,375 | $3,763,338 | 0.65% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
NEW | 153,544 | $3,715,764 | 0.64% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Reduced | 143,167 | $3,622,125 | 0.62% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Added | 358,780 | $3,584,212 | 0.62% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.